FDA Explains Reasons For Delaying, Limiting Or Refusing Inspections In Final Guidance

The US FDA has issued its final guidance defining manufacturer behaviors it deems as hampering the agency’s ability to conduct an inspection. In a previous draft guidance, the agency expanded its longstanding policy on inspections of drug companies to include device makers as well.